Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 04, 2015 8:47 AM ET

Biotechnology

Company Overview of GenSight Biologics SA

Company Overview

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery and development of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based approach with technology platforms of mitochondrial targeting sequence and optogenetics. Its lead product candidates include GS010, an AAV2 containing the human wild-type ND4 gene, which is in Phase Ib clinical trials for the treatment of Leber Hereditary Optic Neuropathy associated with mutation in the ND4 gene; and GS030 that comprises a gene encoding a photoactivatable channelrhodopsin for the treatment of reinitis pigmentosa...

74, rue du Faubourg Saint-Antoine

Paris,  75012

France

12 Employees

Phone:

33 1 76 21 72 20

Fax:

33 1 76 21 72 21

Key Executives for GenSight Biologics SA

Co-Founder, Executive Chairman and Chief Executive Officer
Age: 55
Scientific Founder, Vice Chairman of Scientific & Clinical Advisory Board and Board Observer
Scientific Founder and Chairman of Scientific & Clinical Advisory Board
Scientific Founder and Vice Chairman of Scientific & Clinical Advisory Board
Scientific Founder and Member of Scientific & Clinical Advisory Board
Compensation as of Fiscal Year 2015.

GenSight Biologics SA Key Developments

GenSight Biologics SA Appoints Thomas Gidoin as Chief Financial Officer & Michael Wyzga to Board of Directors

GenSight Biologics SA announced the appointments of Thomas Gidoin as Chief Financial Officer and Michael Wyzga as Independent Director. In this role, Mr. Gidoin is responsible for the company’s corporate and financial development strategies and operations, and will report to Dr. Bernard Gilly, Chief Executive Officer and Chairman of GenSight. Mr. Gidoin brings significant corporate finance and leadership experience to GenSight. Since 2012, he led the Corporate Finance team at DBV Technologies, participating in public offerings and private placements, including the dual listing of the company on the NASDAQ Global Select Market. Prior to that, he worked at Ipsen from 2008 to 2011, as a Senior Financial Analyst within the Group Operations division and later as UK Operations Controller in London. Mr. Gidoin holds Master’s degrees in International Finance from ESGF Paris and in International Management from Neoma Business School in France.

GenSight Biologics SA Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:55 AM

GenSight Biologics SA Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:55 AM. Venue: Waldorf Astoria New York, New York, New York, United States.

GenSight Biologics SA Presents at BIO-Europe Spring 2015, Mar-09-2015 through Mar-11-2015

GenSight Biologics SA Presents at BIO-Europe Spring 2015, Mar-09-2015 through Mar-11-2015. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France. Presentation Date & Speakers: Mar-09-2015, Jean-Philippe Combal, Chief Operating Officer. Mar-11-2015.

Similar Private Companies By Industry

Company Name Region
Alkion Biopharma SAS Europe
Promise Advanced Proteomics Europe
STEM ALPHA Europe
AtlanChim Europe
Qiagen Marseille Société Anonyme Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 7, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GenSight Biologics SA, please visit www.gensight-biologics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.